DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Uramustine
Uramustine
The Chemotherapy of Malignant Disease -Practical and Experimental Considerations
WO 2018/175958 Al 27 September 2018 (27.09.2018) W !P O PCT
US 2006/0165744 A1 Jamil Et Al
Covalent Protein Adduction of Nitrogen Mustards and Related Compounds Vanessa R
Recent Advancements in Uracil and 5-Fluorouracil Hybrids As Potential Anticancer Agents: a Review
Pharmaceutical Appendix to the Tariff Schedule 2
Phenotype-Based Drug Screening Reveals Association Between Venetoclax Response and Differentiation Stage in Acute Myeloid Leukemia
ANTINEOPLASTIC AGENTS (Part-II) by Mrs
HHS Public Access Author Manuscript
ATC Seznam (2019)
Pharmaceutical Waste Identification Checklist – Surgical Center
Hazardous Drug Acknowledgement Statement
Evolution of Nitrogen-Based Alkylating Anticancer Agents
Bioflo Port Chemotherapy Testing Tech Note
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Drug Resistance Profiling of a New Triple Negative Breast Cancer Patient-Derived Xenograft Model Margarite D
(12) Patent Application Publication (10) Pub. No.: US 2016/0220537 A1 GARNER Et Al
Powered Industrial Truck Safety Policy
Top View
Poison Or Antibiotic? a Guide to "Class" Entries
Managing Chemotherapy Waste
(12) United States Patent (10) Patent No.: US 8.497,297 B2 Condon Et Al
Pharmaabkommen A1 E
Hybrid Molecules Based on Distamycin a As Potential Antitumor Agents
Graph Theoretical Analysis, Insilico Modeling and Formulation of Pyrimidine Nanoparticles As P38α MAP Kinases Inhibitors: a Quantitative Proteomics Approach
WO 2016/014553 Al 28 January 2016 (28.01.2016) P O P C T
Example RCRA Waste Codes for Hazardous Waste Pharmaceuticals
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
(12) Patent Application Publication (10) Pub. No.: US 2010/0152284 A1 Brown Et Al
Antitumor Drugs and Their Targets
Example Hazardous Waste Pharmaceuticals
Potential Antineoplastic Structural
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Pharmaceutical Appendix to the Tariff Schedule 2
This Thesis Comes Within Category D
Novel Anticancer Drugs Utilizing Data Mining for Accepted: 17/02/2012 Substituent Substitution Within Uramustine Scaffold
Intravesical Instillation with Mitomycin C Or Bacillus Calmette-Guérin in Non-Muscle Invasive Bladder Cancer
Use of the Comet Assay Technique for Quick and Reliable Prediction of In
Waste Management
Product Data
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri
Antineoplastic Drugs